FIG 1.

Mean change in bacterial density at 24 hours relative to 0-h controls after administration of meropenem (A) and ceftazidime-avibactam (B) against an NDM-harboring E. coli and K. pneumoniae, respectively. Data adapted from 2 contemporary β-lactam dose-ranging studies (46, 51).